Wireless Cardiotocography CTG Monitoring Systems RF Safety Alert
Areazine synthesizes this MHRA medicine alert directly from MHRA's official public data feed. See our methodology for full source attribution and refresh cadence.
MHRA issues safety considerations for wireless CTG systems using RF telemetry due to signal crossover and erroneous traces.
MHRA medicine alert: what the record actually shows
This notice was issued by MHRA on September 17, 2026 and geographically references National. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Medicine Alerts - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Before acting, the primary agency source is available to check alongside this summary. Its related labels are recall, product-safety, mhra, MedicalDevice.
What Happened
The MHRA has conducted a review into the use of wireless cardiotocography (CTG) systems that use radiofrequency (RF) telemetry channels. Signal crossover, erroneous CTG traces and signal dropouts have been identified as patient safety risks.
Which Products Are Affected
Wireless cardiotocography (CTG) monitoring systems that use radiofrequency (RF) telemetry channels. No specific model numbers, quantities or manufacturers are listed in the alert (DSI/2026/012).
What You Should Do
Healthcare professionals should review the MHRA alert for guidance on safe use of these systems.
Why This Matters
Signal issues in fetal monitoring equipment can affect the accuracy of CTG traces used during childbirth.
Source
Original source: MHRA Official Notice ↗
Related Medicine Alerts
All Medicine Alerts →Elsewhere in the country: similar length or severity timing 8
Two Areazine-derived peer sets for this MHRA medicine alert: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (925 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to September 17, 2026.
Frequently Asked Questions
Common questions about this MHRA medicine alert.